OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 12, pp. 1578-1590
Open Access | Times Cited: 13
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 12, pp. 1578-1590
Open Access | Times Cited: 13
Showing 13 citing articles:
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 118-118
Open Access | Times Cited: 29
Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 118-118
Open Access | Times Cited: 29
COVID‐19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network‐Based Approach
Carolina García‐Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Closed Access
Carolina García‐Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Closed Access
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines
Małgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
Blood Reviews (2024) Vol. 65, pp. 101180-101180
Open Access | Times Cited: 4
Małgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
Blood Reviews (2024) Vol. 65, pp. 101180-101180
Open Access | Times Cited: 4
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 895-899
Open Access | Times Cited: 11
Natália B. do Amaral, Tamara Silva Rodrigues, Marcela C Giannini, et al.
Inflammation Research (2023) Vol. 72, Iss. 5, pp. 895-899
Open Access | Times Cited: 11
An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
Zongming Liu, Jiaxuan Li, Shanshan Pei, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Zongming Liu, Jiaxuan Li, Shanshan Pei, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Nirmatrelvir plus ritonavir in COVID-19: a profile of its use
Hannah A. Blair
Drugs & Therapy Perspectives (2022) Vol. 39, Iss. 2, pp. 41-47
Open Access | Times Cited: 12
Hannah A. Blair
Drugs & Therapy Perspectives (2022) Vol. 39, Iss. 2, pp. 41-47
Open Access | Times Cited: 12
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy
Francesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
BioDrugs (2023) Vol. 37, Iss. 5, pp. 675-684
Open Access | Times Cited: 5
Francesco Ciccimarra, Nicoletta Luxi, Chiara Bellitto, et al.
BioDrugs (2023) Vol. 37, Iss. 5, pp. 675-684
Open Access | Times Cited: 5
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
Chiara Oltolini, Andrea Acerbis, Giorgio Orofino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Chiara Oltolini, Andrea Acerbis, Giorgio Orofino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
What do clinicians mean by epidemics' preparedness
Michele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 5, pp. 586-591
Closed Access | Times Cited: 3
Michele Bartoletti, Linda Bussini, Davide Fiore Bavaro, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 5, pp. 586-591
Closed Access | Times Cited: 3
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors’ response
Tzong‐Yow Wu, Pao-Yu Chen, Jann‐Tay Wang, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access
Tzong‐Yow Wu, Pao-Yu Chen, Jann‐Tay Wang, et al.
Journal of Antimicrobial Chemotherapy (2024)
Closed Access
Comparative analysis of antimicrobial drug sensitivity in the population of Kyrgyzstan: Pre-and Post-COVID-19 pandemic
Abdimomunova Begimai Toktobolotovna, Abdumalik Kyzy Nurzamana, Davranbek Kyzy Meerim, et al.
Journal Of Advanced Pharmacy Education And Research (2024) Vol. 14, Iss. 1, pp. 91-96
Closed Access
Abdimomunova Begimai Toktobolotovna, Abdumalik Kyzy Nurzamana, Davranbek Kyzy Meerim, et al.
Journal Of Advanced Pharmacy Education And Research (2024) Vol. 14, Iss. 1, pp. 91-96
Closed Access
Sotrovimab for the Treatment of COVID-19
Zahra Jafari, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 2
Open Access
Zahra Jafari, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 2
Open Access
Treatment of COVID-19: Antivirals, Antibody Products, Immunomodulators, Antithrombotic Therapy, and Supplements
Asuman İnan, Sibel Bölükçü
Cam and Sakura Medical Journal (2023) Vol. 3, Iss. 3, pp. 91-100
Open Access
Asuman İnan, Sibel Bölükçü
Cam and Sakura Medical Journal (2023) Vol. 3, Iss. 3, pp. 91-100
Open Access
